Sunnybrook Announces the Marg Gillespie Precision Oncology Centre to Advance Personalized Cancer Care

Skip to Content News Archives Economy Defence Energy Oil & Gas Renewables Electric Vehicles Mining Commodities Agriculture Real Estate Mortgages Mortgage Rates Finance Banking Insurance Fintech Cryptocurrency Defence Work Wealth Smart Money Wealth Management Investor Personal Finance Family Finance Retirement Taxes High Net Worth FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials More Innovation Information Technology FP500 Podcasts Small Business Lives Told Tails Told Shopping Financial Post Store Obituaries Place a Notice Advertising Advertising With Us Advertising Solutions Postmedia Ad Manager Sponsorship Requests Classifieds Place a Classifieds ad Working Profile Settings My Subscriptions My Offers Newsletters Customer Service FAQ News Economy Energy Mining Real Estate Finance Defence Work Wealth Investor FP Comment Executive Women Puzzmo Newsletters Financial Times Business Essentials This advertisement has not loaded yet, but your article continues below.HomeBusiness Wire News ReleasesPMN Press ReleasesThis section is The content in this section is supplied by Business Wire for the purposes of distributing press releases on behalf of its clients. Postmedia has not reviewed the content. by Business Wire Sunnybrook Announces the Marg Gillespie Precision Oncology Centre to Advance Personalized Cancer CareAuthor of the article:$29 million in philanthropic support is the reason Sunnybrook will create a purpose-built clinical trials hub to accelerate discovery, advance personalized cancer care and increase access to emerging therapies for future patients.THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLYSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.SUBSCRIBE TO UNLOCK MORE ARTICLESSubscribe now to read the latest news in your city and across Canada.Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.Daily content from Financial Times, the world's leading global business publication.Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.Daily puzzles, including the New York Times Crossword.REGISTER / SIGN IN TO UNLOCK MORE ARTICLESCreate an account or sign in to continue with your reading experience.Access articles from across Canada with one account.Share your thoughts and join the conversation in the comments.Enjoy additional articles per month.Get email updates from your favourite authors.THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.Create an account or sign in to continue with your reading experience.Access articles from across Canada with one accountShare your thoughts and join the conversation in the commentsEnjoy additional articles per monthGet email updates from your favourite authorsSign In or Create an AccountTORONTO — Sunnybrook Health Sciences Centre is proud to announce plans to build the Marg Gillespie Precision Oncology Centre, made possible by $29 million in philanthropic support from Sunnybrook’s donor community, including a lead gift from the Gillespie family.This advertisement has not loaded yet, but your article continues below.Expected to open in 2029, the 7,800-square-foot space located within Sunnybrook’s Odette Cancer Centre, will increase Sunnybrook’s capacity to lead cancer research and support a broader range of clinical trials.Get the latest headlines, breaking news and columns.By signing up you consent to receive the above newsletter from Postmedia Network Inc.A welcome email is on its way. If you don't see it, please check your junk folder.The next issue of Top Stories will soon be in your inbox.We encountered an issue signing you up. Please try again“Every patient is unique and so is their cancer. Their treatment should be too,” said Dr. Monika Krzyzanowska, Chief, Odette Cancer Program at Sunnybrook Health Sciences Centre. “This centre will bring that vision to life and give more patients access to the latest therapies and clinical trials in a space designed around their needs. It will strengthen our ability to attract leading talent, partners and conduct high-impact trials that will shape cancer care in Canada.”At Sunnybrook, research and patient care go hand in hand. Building on Sunnybrook’s leadership in research and clinical trials, the future Marg Gillespie Precision Oncology Centre will help strengthen Canada’s capacity to lead more high-impact precision oncology research. The discoveries, innovations and collaborations supported by this work have the potential to improve cancer care for patients in Toronto, across Canada and around the world. Plans for the centre include exam and procedure rooms, clinical trial consultation and monitoring spaces, a biospecimen collection zone with laboratory access and a dedicated nuclear oncology clinic offering precision radioactive treatments.The Odette Cancer Program currently has more than 150 active cancer clinical trials, with nearly 10,000 patients participating in research. The future Marg Gillespie Precision Oncology Centre will build on this momentum by providing innovative, integrated space designed to accelerate discovery, advance personalized cancer care and increase access to new and emerging therapies for future patients.The centre is named in honour of Marg Gillespie, a nurse and single mother who was treated for breast cancer at Sunnybrook. Marg believed there could always be another option, another treatment, and Sunnybrook’s care supported her in pursuing those possibilities throughout her cancer journey. After she passed away in March 2025, her family stepped forward with a lead gift to honour her legacy and determination to fight the disease. Their gift transforms one family’s deeply personal experience into a lasting impact, helping drive research and innovation and offering new hope to patients and families for generations to come.This advertisement has not loaded yet, but your article continues below.“Philanthropy at its best changes what’s possible for patients, and the Marg Gillespie Precision Oncology Centre is a powerful example,” says Kelly Cole, President & CEO, Sunnybrook Foundation. “Our donors are the reason Sunnybrook can invest in space, technology and the expertise needed to make personalized care a reality for more patients. Led by the Gillespie family’s generous gift, this support is creating new possibilities for patients and advancing what Sunnybrook can achieve in cancer care.”This new centre is a key part of Sunnybrook’s broader philanthropic vision to expand access to clinical research and bring promising new treatments to patients faster. It builds on the $41 million philanthropic investment announced in April 2026 to create Sunnybrook Clinical Trials.Learn more about the Marg Gillespie Precision Oncology Centre and how you can support this work through the Sunnybrook Odette Cancer Program.About Sunnybrook Health Sciences CentreSunnybrook Health Sciences Centre is inventing the future of health care with 1.2 million patient visits each year and more than 16,000 dedicated staff, learners and volunteers. An internationally recognized leader in research and education and a full affiliation with the University of Toronto distinguishes Sunnybrook as one of Canada’s premier academic health sciences centres.Sunnybrook specializes in caring for high-risk pregnancies, critically ill newborns and adults, offering specialized rehabilitation and treating and preventing cancer, cardiovascular disease, neurological and psychiatric disorders, orthopaedic and arthritic conditions and traumatic injuries. The Hospital also has a unique and leading national program for the care of Canada’s war veterans.For more information about how Sunnybrook is inventing the future of health care, please visit us online at www.sunnybrook.ca.View source version on businesswire.com: This advertisement has not loaded yet.Notice for the Postmedia NetworkThis website uses cookies to personalize your content (including ads), and allows us to analyze our traffic. Read more about cookies here. By continuing to use our site, you agree to our Terms of Use and Privacy Policy.